Spirulina and Fibroblast Activation: Myofibroblast Differentiation and ECM Remodelling

Fibroblast Activation and Myofibroblast Transition

Myofibroblasts are the primary collagen-producing cells in fibrotic disease. They arise from: (1) tissue-resident fibroblasts (primary source in liver/lung/kidney); (2) portal fibroblasts and hepatic stellate cells (HSCs, in liver); (3) bone marrow-derived fibrocytes; (4) epithelial-mesenchymal transition (EMT, limited contribution). Key inducers of fibroblast-to-myofibroblast transition (FMT): TGF-beta1 (primary driver), PDGF-BB, connective tissue growth factor (CTGF/CCN2), endothelin-1, and mechanical stiffness (integrin-YAP/TAZ mechanosensing). Myofibroblasts express alpha-SMA (ACTA2), ED-A fibronectin, and produce collagen I/III and fibronectin in excess.

TGF-beta/SMAD3 and Collagen Induction

TGF-beta1 binding to TGFBR2 recruits and transphosphorylates TGFBR1 (ALK5), activating SMAD2/3 (phosphorylated at Ser423/425). pSMAD2/3 partners with SMAD4, translocates to nucleus, and binds SMAD-binding elements (SBE: GTCT/AGAC) to induce: COL1A1/COL1A2 (collagen I), COL3A1, ACTA2 (alpha-SMA), CTGF, PAI-1/SERPINE1 (plasminogen activator inhibitor). SMAD7 (induced by TGF-beta as negative feedback) recruits SMURF2 E3 ligase to TGFBR1 for ubiquitination. Spirulina reduces TGF-beta1 production (via NF-kB suppression in inflammatory cells), and PCB reduces SMAD3 phosphorylation in hepatic stellate cell models, directly attenuating fibrotic gene transcription.

Nrf2-HO-1 Anti-fibrotic Axis

Nrf2 activation suppresses fibrosis through multiple mechanisms: (1) HO-1-derived CO and bilirubin suppress TGF-beta1-driven SMAD3 phosphorylation; (2) Nrf2 directly suppresses alpha-SMA (ACTA2) promoter by competing with SMAD3 for co-activator CBP/ p300; (3) Nrf2 reduces oxidative stress that activates latent TGF-beta (through thrombospondin-1 oxidation); (4) Nrf2-induced GSH maintains redox-sensitive SMAD7 (protecting it from oxidative degradation, preserving its SMAD3-inhibitory role). Spirulina supplementation reduces hepatic fibrosis markers in CCl4 and bile duct ligation rodent models, with Nrf2-HO-1 consistently identified as the mechanistic basis.

MMP/TIMP Balance and Matrix Degradation

Matrix metalloproteinases (MMP1/2/3/9) degrade fibrillar collagens, fibronectin, and laminin. Tissue inhibitors of metalloproteinases (TIMP1/2/3/4) block MMP activity competitively. In fibrosis, the MMP/TIMP balance shifts toward TIMP dominance: TGF-beta1 upregulates TIMP1 while PDGF and IL-1 regulate MMPs. NF-kB drives MMP9 and MMP13 in inflammatory contexts. Spirulina reduces the TIMP1/MMP2 ratio in liver fibrosis models, consistent with NF-kB suppression reducing TIMP1 transcription and Nrf2-driven antioxidant protection preventing MMP inactivation by oxidative modification of their catalytic Zn centres.

FAP+ Cancer-Associated Fibroblasts (CAFs)

Fibroblast activation protein (FAP/seprase) is a serine protease expressed on myofibroblasts and cancer-associated fibroblasts (CAFs) in tumour stroma. FAP+ CAFs secrete CXCL12, TGF-beta, VEGF-A, and IL-6 to promote tumour immune exclusion, EMT, and angiogenesis. CAF-derived TGF-beta is a major mechanism of resistance to immune checkpoint inhibitors. Spirulina's suppression of TGF-beta production (via NF-kB/PCB) would reduce CAF activation and CXCL12-mediated T cell exclusion, potentially synergising with PD-1/PD-L1 inhibitors.

YAP/TAZ Mechanosensing in Fibrosis

YAP (YAP1) and TAZ (WWTR1) are mechano-transducers that shuttle between cytoplasm (Hippo pathway active: LATS1/2 phospho-Ser127 YAP, sequestered by 14-3-3) and nucleus (stiff matrix, nuclear YAP activates TEAD targets: CTGF, CYR61, ANKRD1). Matrix stiffness characteristic of fibrotic tissue (collagen crosslinking via LOX) activates YAP/TAZ, creating a vicious cycle of fibroblast activation and ECM stiffening. AMPK phosphorylates AMOTL1/AMOTL2 (motin family), which sequester YAP in the cytoplasm. Spirulina's AMPK activation thus provides a mechanosensing brake on fibrosis amplification independent of TGF-beta signalling.